Silva Pharmaceuticals Limited (DSE:SILVAPHL)

bluebird bio Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	1,433	1,952	2,948	3,290	2,689	2,498
Market Cap Growth	-25.16%	-33.80%	-10.37%	22.34%	7.65%	-16.46%
Enterprise Value	1,334	1,820	2,813	3,132	2,480	2,196
Last Close Price	10.50	14.16	21.29	23.42	18.63	16.83
PE Ratio	-	-	89.14	32.17	22.44	21.00
PS Ratio	3.32	3.26	4.11	4.22	3.36	3.27
PB Ratio	0.66	0.87	1.26	1.42	1.18	1.14
P/TBV Ratio	0.66	0.87	1.26	1.42	1.19	1.14
P/FCF Ratio	-	-	-	-	32.71	-
P/OCF Ratio	236.91	570.94	42.06	20.45	16.87	16.58
EV/Sales Ratio	3.09	3.04	3.92	4.02	3.10	2.88
EV/EBITDA Ratio	-	157.08	26.22	17.96	11.96	10.51
EV/EBIT Ratio	-	-	62.82	28.02	17.45	15.65
EV/FCF Ratio	-53.60	-	-	-	30.16	-
Debt / Equity Ratio	0.02	0.02	0.03	0.04	0.02	0.02
Debt / EBITDA Ratio	-	3.95	0.56	0.55	0.20	0.21
Debt / FCF Ratio	-	-	-	-	0.52	-
Asset Turnover	0.18	0.24	0.28	0.31	0.33	0.32
Inventory Turnover	0.68	0.89	1.00	1.04	1.07	1.11
Quick Ratio	5.50	5.17	5.11	3.76	6.13	3.15
Current Ratio	12.64	12.67	11.61	7.70	12.15	6.82
Return on Equity (ROE)	-5.87%	-2.81%	1.42%	4.45%	5.36%	5.49%
Return on Assets (ROA)	-2.96%	-1.20%	1.11%	2.80%	3.62%	3.69%
Return on Capital (ROIC)	-3.10%	-1.25%	1.16%	2.95%	3.90%	4.01%
Return on Capital Employed (ROCE)	-	-	1.90%	4.60%	6.00%	6.10%
Earnings Yield	-9.18%	-3.30%	1.12%	3.11%	4.46%	4.76%
FCF Yield	-1.74%	-1.52%	-0.57%	-0.51%	3.06%	-0.85%
Dividend Yield	0.95%	0.71%	0.47%	1.28%	2.68%	2.97%
Payout Ratio	-	-	75.66%	46.70%	39.46%	44.52%
Total Shareholder Return	0.95%	0.71%	0.47%	1.28%	2.68%	2.97%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.